ESR1 and breast carcinoma: The estrogen receptor α (ERα), a key player in breast cancer development, is influenced by RNF168, which interacts with the promoter region of ERα to enhance its transcriptional activity, thereby boosting the ERα signaling cascade and promoting the proliferation of ERα-positive breast cancer cells [41].